...
首页> 外文期刊>American Journal of Physiology >Aldosterone-induced mesangial cell proliferation is mediated by EGF receptor transactivation.
【24h】

Aldosterone-induced mesangial cell proliferation is mediated by EGF receptor transactivation.

机译:醛固酮诱导的乳房细胞增殖由EGF受体转基因介导。

获取原文
获取原文并翻译 | 示例

摘要

Aldosterone (Aldo) stimulates glomerular mesangial cell (MC) proliferation, in part, through an ERK1/2-dependent pathway. In this study, we examined whether Aldo activation of ERK1/2 in MC is mediated through redox-dependent EGF receptor (EGFR) transactivation, as well as the involvement of other signaling mechanisms in Aldo-induced MC proliferation. Aldo increased human MC proliferation, as determined by [(3)H]thymidine incorporation and cell counts. This increase in proliferation was blocked by inhibition of the mineralocorticoid receptor (MR). Continuing our observations downstream in the signaling pathway, we examined the ability of Aldo to activate both the Ras/MAPK and the PI3K signaling pathways. Aldo increased Ki-RasA and Ki-RasA:GTP levels, and sequentially phosphorylated c-Raf, MAPK kinase (MEK1/2), and ERK1/2. Ki-RasA small interfering RNA (siRNA), the c-Raf inhibitor GW5074, and the MEK1/2 inhibitor PD98059 reduced Aldo-induced cell proliferation by approximately 65%. Aldo also increased phosphorylation of PI3K, Akt, the mammalian target of rapamycin (mTOR), and the 70-kDa ribosomal S6 kinase (p70S6K1). Inhibition of the PI3K pathways by the selective PI3K inhibitor LY 294002, an Akt inhibitor, or the mTOR inhibitor rapamycin reduced cell proliferation by 51%. Combining LY 294002 and PD98059 completely blocked Aldo-induced MC proliferation. Next, we confirmed that Aldo exerts its effect on MAPK and PI3K activation, as well as on cell proliferation, by activating the EGFR. Pretreatment with the EGFR antagonist AG1478 inhibited MC proliferation, as well as the activation of Ras/MAPK and PI3K/Akt, suggesting that Ras/MAPK and PI3K/Akt activation occur downstream of EGFR activation. Finally, we examined the role of reactive oxygen species (ROS) in Aldo-induced transactivation of the EGFR. Aldo-induced ROS were predominantly generated by mitochondria. Pretreatment with the antioxidant N-acetyl-l-cysteine, catalase, SOD, mitochondrial respiratory chain complex I inhibitor rotenone (Rot), NADPH oxidase inhibitor apocynin, and DPI significantly inhibited Aldo-stimulated MC proliferation as well as EGFR transactivation. However, Rot reduced MC proliferation more potently than apocynin and DPI. In conclusion, Aldo stimulated cell proliferation through MR-mediated, redox-sensitive EGFR transactivation, which was dependent on the Ki-RasA/c-Raf/MEK/ERK and PI3K/Akt/mTOR/p70S6K1 signaling pathways in human MCs.
机译:醛固酮(ALDO)部分通过ERK1 / 2依赖性途径刺激肾小球髓细胞(MC)增殖。在这项研究中,我们检查了通过氧化还原依赖性EGF受体(EGFR)转移介导MC中ERK1 / 2的Aldh1 / 2的Aldo激活,以及其他信号传导机制在Aldo诱导的MC增殖中的累积。 Aldo增加人MC增殖,如[(3)H]胸苷掺入和细胞计数确定。通过抑制Minellocorcoid受体(MR)来阻断增殖增加。继续我们在信号通道下游的观察,我们检查了ALDO激活RAS / MAPK和PI3K信号通路的能力。 Aldo增加了Ki-RASA和Ki-RASA:GTP水平,并依次磷酸化的C-RAF,MAPK激酶(MEK1 / 2)和ERK1 / 2。 Ki-Rasa小干扰RNA(siRNA),C-RAF抑制剂GW5074和MEK1 / 2抑制剂PD98059将Aldo诱导的细胞增殖降低约65%。 Aldo还增加了PI3K,Akt,哺乳动物催乳素靶标的磷酸化(MTOR)和70-KDA核糖体S6激酶(P70S6K1)。选择性PI3K抑制剂LY 294002,AKT抑制剂或MTOR抑制剂雷帕霉素的抑制减少了细胞增殖51%。结合Ly 294002和PD98059完全阻止了Aldo诱导的MC增殖。接下来,我们证实Aldo通过激活EGFR来施加对MAPK和PI3K活化的影响,以及细胞增殖。用EGFR拮抗剂AG1478的预处理抑制MC增殖,以及RAS / MAPK和PI3K / AKT的激活,表明RAS / MAPK和PI3K / AKT激活发生在EGFR激活下游。最后,我们研究了反应性氧物种(ROS)在EGFR的aldog诱导的转移中的作用。 Aldo诱导的ROS主要由线粒体产生。用抗氧化N-乙酰基-1-半胱氨酸的预处理,过氧化氢酶,SOD,线粒体呼吸链复合物I抑制剂转胸(腐肉),NADPH氧化酶抑制剂Apocynin,DPI显着抑制了Aldo刺激的MC增殖以及EGFR转移激活。然而,比Apocynin和DPI更有效地腐烂MC增殖。总之,Aldo通过MR介导的氧化还原敏感EGFR转移激活细胞增殖,其依赖于人MCS中的Ki-Rasa / C-Raf / Mek / Erk和Pi3k / Akt / mtor / p70s6k1信号传导途径。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号